• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

BioH aquires Intralock

























JS JE. And TG in a circle jerk thinking they outsmarted bio. A shit product for shit money. Maybe JS can buy a bigger house for him and JE. An unreal example of clueless losers getting lucky from taking orders like a dog from TG for years.